Sukhatme Mayukh
Insider CIK 1750050 · ROIV See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-10-16 | 2026-10-20 | 19,976 | $33.53 | $669.8K | 18,563,884 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-30 | 2026-10-02 | 46,879 | $36.57 | $1.71M | 18,583,860 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 144,756 | — | $0 | 13,224,363 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-21 | 2026-08-21 | 144,756 | $3.85 | $557.3K | 18,775,495 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-21 | 2026-08-21 | 144,756 | $36.48 | $5.28M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 144,756 | — | $0 | 13,224,363 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-21 | 2026-08-21 | 144,756 | $36.48 | $5.28M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-21 | 2026-08-21 | 144,756 | $3.85 | $557.3K | 18,775,495 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 17,519 | — | $0 | 13,369,119 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-20 | 2026-08-21 | 17,519 | $3.85 | $67.4K | 18,648,258 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-20 | 2026-08-21 | 17,519 | $37.30 | $653.5K | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 17,519 | — | $0 | 13,369,119 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-20 | 2026-08-21 | 17,519 | $37.30 | $653.5K | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-20 | 2026-08-21 | 17,519 | $3.85 | $67.4K | 18,648,258 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-19 | 2026-08-21 | 172,899 | — | $0 | 13,386,638 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-19 | 2026-08-21 | 172,899 | $3.85 | $665.7K | 18,803,638 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-19 | 2026-08-21 | 172,899 | $37.17 | $6.43M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-19 | 2026-08-21 | 172,899 | — | $0 | 13,386,638 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-19 | 2026-08-21 | 172,899 | $37.17 | $6.43M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-19 | 2026-08-21 | 172,899 | $3.85 | $665.7K | 18,803,638 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-18 | 2026-08-18 | 136,942 | — | $0 | 13,559,537 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-18 | 2026-08-18 | 31,801 | $37.18 | $1.18M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-18 | 2026-08-18 | 31,801 | $3.85 | $122.4K | 18,662,540 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-18 | 2026-08-18 | 105,141 | $36.59 | $3.85M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-18 | 2026-08-18 | 105,141 | $3.85 | $404.8K | 18,735,880 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-18 | 2026-08-18 | 136,942 | — | $0 | 13,559,537 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-18 | 2026-08-18 | 31,801 | $37.18 | $1.18M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-18 | 2026-08-18 | 31,801 | $3.85 | $122.4K | 18,662,540 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-18 | 2026-08-18 | 105,141 | $36.59 | $3.85M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-18 | 2026-08-18 | 105,141 | $3.85 | $404.8K | 18,735,880 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-17 | 2026-08-18 | 284,707 | — | $0 | 13,696,479 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-17 | 2026-08-18 | 284,707 | $36.25 | $10.32M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-17 | 2026-08-18 | 284,707 | $3.85 | $1.10M | 18,915,446 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-17 | 2026-08-18 | 284,707 | — | $0 | 13,696,479 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-17 | 2026-08-18 | 284,707 | $36.25 | $10.32M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-17 | 2026-08-18 | 284,707 | $3.85 | $1.10M | 18,915,446 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-14 | 2026-08-18 | 243,177 | — | $0 | 13,981,186 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-14 | 2026-08-18 | 243,177 | $3.85 | $936.2K | 18,873,916 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-14 | 2026-08-18 | 243,177 | $36.23 | $8.81M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-08-14 | 2026-08-18 | 243,177 | — | $0 | 13,981,186 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-08-14 | 2026-08-18 | 243,177 | $36.23 | $8.81M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-08-14 | 2026-08-18 | 243,177 | $3.85 | $936.2K | 18,873,916 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-06-30 | 2026-07-02 | 46,878 | $35.39 | $1.66M | 18,630,739 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-06-26 | 2026-06-29 | 500,000 | — | $0 | 14,224,363 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-26 | 2026-06-29 | 500,000 | $34.08 | $17.04M | 18,677,617 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-06-26 | 2026-06-29 | 500,000 | $3.85 | $1.93M | 19,177,617 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-06-25 | 2026-06-29 | 500,000 | — | $0 | 14,724,363 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-25 | 2026-06-29 | 500,000 | $34.13 | $17.07M | 18,677,617 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-06-25 | 2026-06-29 | 500,000 | $3.85 | $1.93M | 19,177,617 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-03-31 | 2026-04-01 | 187,512 | $27.70 | $5.19M | 18,677,617 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-03-30 | 2026-04-01 | 1,306,889 | $11.50 | $15.03M | 0 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-03-30 | 2026-04-01 | 58,391 | — | $0 | 18,894,938 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-03-30 | 2026-04-01 | 29,809 | $26.41 | $787.3K | 18,865,129 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-02-09 | 2026-02-11 | 651,558 | — | $0 | 0 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2026-02-09 | 2026-02-11 | 312,117 | $26.47 | $8.26M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-02-09 | 2026-02-11 | 651,558 | $12.68 | $8.26M | 19,488,105 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-09 | 2026-02-11 | 339,441 | $26.47 | $8.99M | 19,148,664 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-31 | 2025-12-31 | 2,449,877 | — | $0 | 95,718 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-31 | 2025-12-31 | 2,449,877 | $12.68 | $31.06M | 21,286,424 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-31 | 2025-12-31 | 1,018,995 | $21.71 | $22.12M | 20,267,429 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-31 | 2025-12-31 | 1,430,882 | $21.71 | $31.06M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-29 | 2025-12-31 | 748,358 | — | $0 | 555,840 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-29 | 2025-12-31 | 436,485 | $21.74 | $9.49M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-29 | 2025-12-31 | 748,358 | $12.68 | $9.49M | 19,584,905 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-29 | 2025-12-31 | 311,873 | $21.74 | $6.78M | 19,273,032 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2025-12-17 | 2025-12-19 | 59,513 | — | $0 | 1,304,198 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2025-12-17 | 2025-12-19 | 59,513 | $12.68 | $754.6K | 18,896,060 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-17 | 2025-12-19 | 26,831 | $23.09 | $619.5K | 18,869,229 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-12-17 | 2025-12-19 | 32,682 | $23.09 | $754.6K | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2024-12-26 | 2024-12-26 | 689,495 | — | $0 | 15,224,363 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-12-26 | 2024-12-26 | 689,495 | $12.01 | $8.28M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2024-12-26 | 2024-12-26 | 689,495 | $3.85 | $2.65M | 19,526,042 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2024-12-24 | 2024-12-26 | 185,946 | — | $0 | 15,913,858 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2024-12-24 | 2024-12-26 | 185,946 | $3.85 | $715.9K | 19,022,493 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-12-24 | 2024-12-26 | 185,946 | $12.00 | $2.23M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2024-12-23 | 2024-12-26 | 10,796 | — | $0 | 16,099,804 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2024-12-23 | 2024-12-26 | 10,796 | $3.85 | $41.6K | 18,847,343 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-12-23 | 2024-12-26 | 10,796 | $12.00 | $129.6K | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2024-12-18 | 2024-12-20 | 412,584 | — | $0 | 16,110,600 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2024-12-18 | 2024-12-20 | 412,584 | $3.85 | $1.59M | 19,249,131 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-12-18 | 2024-12-20 | 412,584 | $12.05 | $4.97M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-12-03 | 2024-12-05 | 3,651,985 | $12.21 | $44.59M | 18,836,547 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-07-26 | 2024-07-30 | 1,836,547 | — | $0 | 5,488,532 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-07-26 | 2024-07-30 | 17,000,000 | — | $0 | 22,488,532 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2024-03-30 | 2024-04-02 | 1,856,163 | $6.40 | $11.88M | 0 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2024-03-30 | 2024-04-02 | 729,081 | — | $0 | 4,018,196 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2024-03-30 | 2024-04-02 | 366,211 | $10.54 | $3.86M | 3,651,985 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-12-27 | 2023-12-29 | 28,411 | $11.50 | $326.7K | 1,306,889 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-12-27 | 2023-12-29 | 159,100 | $6.40 | $1.02M | 1,856,163 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-12-27 | 2023-12-29 | 71,365 | — | $0 | 3,289,115 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 28,411 | $11.50 | $326.7K | 1,335,300 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 53,033 | $6.40 | $339.4K | 2,015,263 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-09-27 | 2023-09-29 | 27,790 | — | $0 | 3,217,750 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-08-27 | 2023-08-29 | 53,033 | $6.40 | $339.4K | 2,068,296 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-08-27 | 2023-08-29 | 22,565 | — | $0 | 3,189,960 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-07-27 | 2023-07-31 | 106,067 | $6.40 | $678.8K | 2,121,329 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-07-27 | 2023-07-31 | 43,212 | — | $0 | 3,167,395 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2023-05-27 | 2023-05-31 | 318,199 | $6.40 | $2.04M | 2,227,396 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2023-05-27 | 2023-05-31 | 99,458 | — | $0 | 3,124,183 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2022-04-20 | 2022-04-22 | 16,523,184 | — | $0 | 16,523,184 | SEC↗ |